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Abstract: Dietary protein represents an important nutrient 
for bone health and thereby for the prevention of osteopo-
rosis. Besides its role as a brick provider for building the 
organic matrix of skeletal tissues, dietary protein stimu-
lates the production of the anabolic bone trophic factor 
IGF-I (insulin-like growth factor I). The liver is the main 
source of circulating IGF-I. During growth, protein under-
nutrition results in reduced bone mass and strength. 
Genetic defect impairing the production of IGF-I mark-
edly reduces bone development in both length and width. 
The serum level of IGF-I markedly increases and then 
decreases during pubertal maturation in parallel with the 
change in bone growth and standing height velocity. The 
impact of physical activity on bone structure and strength 
is enhanced by increased dietary protein consumption. 
This synergism between these two important environ-
mental factors can be observed in prepubertal boys, thus 
modifying the genetically determined bone growth trajec-
tory. In anorexia nervosa, IGF-I is low as well as bone min-
eral mass. In selective protein undernutrition, there is a 
resistance to the exogenous bone anabolic effect of IGF-I. 
A series of animal experiments and human clinical trials 
underscore the positive effect of increased dietary intake 
of protein on calcium-phosphate economy and bone 
balance. On the contrary, the dietary protein-induced 
acidosis hypothesis of osteoporosis is not supported by 
several experimental and clinical studies. There is a direct 
effect of amino acids on the local production of IGF-I by 
osteoblastic cells. IGF-I is likely the main mediator of the 
positive effect of parathyroid hormone (PTH) on bone 
formation, thus explaining the reduction in fragility frac-
tures as observed in PTH-treated postmenopausal women. 
In elderly women and men, relatively high protein intake 
protects against spinal and femoral bone loss. In hip frac-
ture patients, isocaloric correction of the relatively low 
protein intake results in: increased IGF-I serum level, sig-
nificant attenuation of postsurgical bone loss, improved 
muscle strength, better recovery, and shortened hospital 
stay. Thus, dietary protein contributes to bone health from 
early childhood to old age. An adequate intake of protein 
should be recommended in the prevention and treatment 
of osteoporosis.
Keywords: anorexia nervosa; bone acquisition; dietary 
protein; elderly; fragility fracture; IGF-I; osteoporosis; 
postmenopausal women.
Historical aspects
Two discoveries were essential for the development of our 
knowledge on the relation between insulin-like growth 
factor I (IGF-I) and dietary protein. First, the identification 
of IGF-I as a factor distinct from insulin. Second, the influ-
ence of dietary components on the production of IGF-I for-
merly and transiently also designated “somatomedin-C”.
In 1963, Froesch and his colleagues discovered that the 
human serum contained an insulin-like activity that was 
nonsuppressible by insulin antibodies [1]. Moreover, in 
contrast to insulin, this activity was neither influenced by 
an overnight fast nor by an oral glucose load [1]. Between 
1983 and 1985, dietary protein was recognized as an impor-
tant macronutrient in the regulation of this insulin-like 
activity [2–4]. Before the publication of these key nutri-
tion-related observations, Daughaday and his colleagues 
discovered that a serum biological activity increased the 
sulfate uptake in cartilaginous glycosaminoglycans [5]. 
Later on, these authors proposed to designate this sulfa-
tion factor by the term “somatomedin-C” [6]. Then, this 
factor was shown to be both structurally and biologically 
identical to IGF-I [7, 8]. In human adults, variations in 
the serum level of somatomedin-C/IGF-I during fasting 
and refeeding were highly correlated with the nitrogen 
balance [2]. These early findings forecast that IGF-I will be 
shown to play a key role for increasing protein synthesis 
and decreasing protein degradation in many organs and 
tissues, particularly in skeletal muscle [9]. Measurement 
of somatomedin-C/IGF-I in serum was then demonstrated 
to be a means for monitoring the response of malnour-
ished patients to nutritional intervention [4]. In clinical 
settings, serum IGF-I was a much more sensitive index of 
nutritional status than the concentrations of prealbumin, 
transferrin, and retinol-binding protein [4].
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During the next two decades, the development of 
technical and clinical tools made it possible to appreciate 
that the dietary protein-IGF-I axis was an important nutri-
tional-hormonal link in bone health and diseases [10]. 
This concept was experimentally documented in both 
animal model of osteoporosis [11, 12] and in hip fracture 
patients [13–15].
Proteins in bone
Quantitative aspects
A rough estimate of protein mass in bone would amount 
to 2.0 kg in a healthy adult man of 70 kg with average body 
mass index (BMI), taken as a classical reference model. In 
comparison, the total mass of protein contained in skel-
etal muscle is 5.0 kg [16]. Assuming that the protein mass 
corresponds to about 19% of body weight [17], the total 
mass of protein would amount to 13.3 kg for 70 kg b.w. The 
distribution of protein corresponds to 15% and 37.6% in 
bone and skeletal muscle, respectively. Thus, bone and 
skeletal muscle taken together contain more than 50% of 
total body proteins.
Qualitative aspects
Bone is a composite tissue made up of organic matrix, 
mineral water, and cells. Collagen type I represents about 
98% of total bone proteins. Bone mineral, an impure form 
of hydroxyapatite, is located within and between colla-
gen fibrils. The main non-collagenous proteins are osteo-
calcin, osteopontin, sialoprotein, and osteonectin [18]. 
In the process of bone modeling, mainly during growth, 
and remodeling during adulthood, the organic matrix is 
formed and resorbed. Molecular products of these two 
processes, particularly from type I collagen, are released 
into the systemic extracellular compartment. They can be 
chemically analyzed and used as markers of bone forma-
tion and resorption [19–21]. Other non-collagenic bone 
proteins such as tartrate-resistant acid phosphatase-5b, 
specific bone alkaline phosphatase, or osteocalcin are 
also released during the process of bone remodeling. They 
are detectable in the systemic extracellular compartment 
and are also used to estimate the rate of bone remodeling, 
as well as its changes in response to physical, pharmaceu-
tical, or nutritional interventions [19–21].
Protein from food is required to promote bone forma-
tion. As for any other organs of the body, the synthesis 
of intracellular and extracellular bone protein and other 
nitrogen-containing compounds is dependent upon the 
supply of amino acids. Besides this role as “brick sup-
plier”, proteins, through their amino acid constituents, 
can influence bone mineral economy and metabolism. 
This influence is mediated, at least in part, by the produc-
tion and action of IGF-I (see below).
IGF-I production and action 
in relation to food intake
IGF-I is a 70-amino acid residue single-chain polypeptide. 
It is expressed in most tissues of the body. Nevertheless, 
liver-produced IGF-I is the main source of circulating IGF-I 
[22, 23]. Growth hormone (GH) is the principal hormonal 
stimulus of IGF-I. However, in food-restricted humans, GH 
secretion is not responsible for the decline in IGF-I pro-
duction [24].
IGF-I acts through the IGF-I receptor (IGF-IR) which is 
a tyrosine kinase that activates several intracellular sign-
aling pathways (for review see [22]). There is an apparent 
similarity of IGF-I and insulin receptor. However, activa-
tion of these two receptors results in distinct effects on 
gene expression and function [22]. IGF-I primarily stimu-
lates growth and cell survival, whereas insulin controls 
carbohydrates, lipid, and protein metabolism. In con-
trast to IGF-I, IGF-II that binds to a receptor distinct from 
IGF-IR does not appear to have further postnatal effects 
on growth [25].
In dietary restriction such as fasting, the number of 
growth hormone receptors (GHRs) in the liver is decreased. 
This effect is associated with a reduction in the IGF-I gene 
expression. Nutritional deprivation impairs both tran-
scriptional and post-transcriptional mechanisms that 
contribute to the decline in circulating IGF-I [26]. Diet 
restriction also enhances the clearance and degradation 
of serum IGF-I, two processes that add to the lowering of 
its circulating level [26]. In young rats, carcass growth is 
impaired under protein restriction despite normalization 
of serum IGF-I concentration by exogenous administra-
tion [27]. In adult rats, this resistance to the action of IGF-I 
under protein restriction was further documented at the 
bone cellular level [12]. Thus, protein restriction induced 
osteoblastic resistance to the action of administered 
rhIGF-I/IGFBP-3 complex, with failure to increase both 
cancellous and periosteal bone formation [12]. In response 
to variations in protein intake, the changes in circulating 
IGF-I can be observed in absence of any differences in 
the dietary supply of energy as observed in both rigorous 
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experimental conditions in adult rats [11, 12] and in a ran-
domized clinical trial in hip fracture patients [14].
Dietary protein-IGF-I axis on bone 
mineral economy and metabolism
Enhanced IGF-I production linked to food protein exerts 
a favorable impact on bone mineral economy by a dual 
renal action. IGF-I stimulates the kidney production and 
increases the circulating level of 1,25 dihydroxyvitamin 
D (1,25D) [28–31], the active form of vitamin D (Figure 1). 
This vitamin D metabolite in turn boosts the intestinal 
absorption of both calcium (Ca) and inorganic phosphate 
(Pi). The second action of IGF-I at the kidney level is to 
increase the tubular reabsorption of Pi. Through this dual 
activity of IGF-I, the concentration of Ca and Pi in the sys-
temic extracellular compartment rises and thereby posi-
tively influences the process of bone mineralization [33]. 
The indirect positive effect of protein intake on intestinal 
Ca absorption, via the IGF-I – 1,25D link, is combined with 
a direct stimulatory effect of amino acids such as argi-
nine and lysine on Ca translocation from the luminal to 
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Figure 1: Role of dietary protein on Ca-Pi economy and bone health.
The hepatic production of insulin-like growth factor-I (IGF-I), which 
is under the positive influence of the growth hormone (GH), is also 
stimulated by amino acids (a.a.). IGF-I exerts a direct action on bone 
anabolism. In addition, at the kidney level, IGF-I increases both 
1,25,dihydroxyvitamin D (1,25D) formation from 25-hydroxyvitamin 
D (25D) and the tubular reabsorption (TR) of Pi. By this dual renal 
action, IGF-I favors a positive balance of calcium and Pi. Moreover, 
a.a. can directly stimulate the intestinal absorption of calcium that 
can account for the increased urinary calcium excretion observed 
with high protein diet. 25D is formed in the liver from vitamin D, 
which is supplied from both dietary and cutaneous sources. Figure 
reproduced from reference [32].
the contraluminal side of the intestinal mucosa [34, 35] 
(Figure 1). Amino acids might activate the Ca-sensing 
receptors (CaRs) [36] and thereby increase the transloca-
tion of Ca through the channels (TRP)V5 and/or TRPV6 
localized in the intestinal epithelium [37, 38] (for review 
see also [39–41]). Quantitatively, the enhanced intestinal 
Ca absorption to a large extent explains the associated 
calciuria. This quantitative matching makes it unlikely 
that a source other than gut would contribute to the 
dietary protein-induced increase in urinary Ca excretion 
[42, 43]. This notion is corroborated by the fact that rela-
tively high protein intake is not associated with a nega-
tive Ca balance [42, 43]. Furthermore, reduced intestinal 
Ca absorption and increased serum level of both parathy-
roid hormone (PTH) and 1,25D are observed when healthy 
women are exposed to a relatively low (0.7 g/kg/day) as 
compared to medium (1.0 g/kg/day) or high (2.1 g/kg/day) 
protein diet [44, 45]. By using Ca kinetics in human, there 
was no increase in bone resorption in response to a high 
protein diet inducing a marked elevation in both intesti-
nal absorption and urinary excretion of Ca [35]. The net 
bone balance corresponding to the difference between 
bone resorption (Vo−) and bone formation (Vo+) was not 
reduced by the high protein diet [35]. Thus, a series of 
animal experiments and human clinical investigations 
underscore the positive effect of increased dietary intake 
of protein on Ca-Pi economy and bone balance.
In sharp contrast with the evidence described above, 
it has been alleged that dietary proteins, particularly 
those from animal sources, might be deleterious to bone 
health by inducing chronic metabolic acidosis eventu-
ally leading to osteoporosis. Over the last decades, this 
apparently attractive hypothesis has prompted several 
investigators to explore in epidemiologic studies whether 
consumption of high animal protein diet would be asso-
ciated with either decreased areal bone mineral density 
(aBMD) or bone mineral content (BMC), or increased inci-
dence of fragility fractures, particularly those occurring at 
the level of the proximal femur (see below). Nevertheless, 
several arguments have been raised against the dietary 
protein-induced acidosis hypothesis of osteoporosis [37, 
43, 46, 47], a theory that disregards the essential homeo-
static role of the kidney in the regulation of the acid-base 
balance [48]. Results from clinical investigation indi-
cate that high protein diet induces neither a negative Ca 
balance nor acceleration in bone resorption rate [35, 49, 
50]. The hypothesis that dietary protein, at an intake level 
leading to increased titratable acid and decreased pH in 
urine, would cause systemic acidosis and induce deleteri-
ous consequences on Ca economy and bone integrity has 
been refuted in several recent reviews and meta-analysis 
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[37, 43, 46, 48, 51–53]. Furthermore, two other original 
reports did not sustain the hypothesis that high dietary 
acid load might be detrimental to bone by accelerating the 
age-related decline in aBMD and increase the incidence of 
fragility fracture [54, 55].
Furthermore, there is no consistent evidence for supe-
riority of vegetal over animal protein on Ca metabolism 
and bone health. In fact, animal protein could be more 
efficacious than soy or vegetable protein for promoting 
bone growth in a laboratory animal model of skeletal 
development [56] or for preventing hip fracture in post-
menopausal women [57].
Local role of IGF-I at the bone level 
in response to amino acids and PTH
There is direct evidence that amino acids such as arginine 
can stimulate the local production of IGF-I by osteoblastic 
cells [58]. This effect is associated with increased osteo-
blastic cell proliferation and collagen synthesis [58]. There 
is also evidence that IGF-I is the main mediator of the bone 
anabolic effect of PTH [59]. This PTH-IGF-I link explains, 
at least in part, the marked positive effect of intermittent 
PTH therapy on bone formation and bone mass as well 
as on fragility fracture reduction, as observed in a rand-
omized controlled trial (RCT) carried out in osteoporotic 
women [60].
Protein intake, IGF-I, and bone 
acquisition
Bone mass and strength achieved by the end of the growth 
period, simply designated as “peak bone mass (PBM)”, 
plays an essential part in the risk of osteoporotic fractures 
occurring in adulthood. It is considered that an increase in 
PBM by 1.0 standard deviation would reduce by 50% the 
fragility fracture risk (see for review [61]). The genetically 
determined trajectory of bone mass development can be, 
to a certain extent, modulated by modifiable environmen-
tal factors (Figure 2). Among these factors, physical activ-
ity and nutrition are key determinants in the acquisition 
of bone mass during growth. Growing bones are usually 
more responsive to mechanical loading [62] and bone 
trophic nutrients [61] than adult bones. Furthermore, the 
impact seems to be stronger before than during or after 
the period of pubertal maturation. Among nutrients that 
can specifically interact with bone metabolism, Ca sup-
plementation has been extensively studied from infancy 
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Figure 2: Determinants of bone mass and strength development 
from birth to maturity.
In healthy human subjects, four main determinants – genetics, 
hormones, nutrition, and mechanical forces – influence bone 
mass and strength from birth to the end of the second decade. At 
this time maximal value, the so-called peak bone mass (PBM) is 
virtually attained. As depicted on the right, these four factors are 
interconnected; for instance, an increased protein intake enhances 
the positive impact of physical activity on bone growth. The curves 
of the diagram on the left illustrate the wide range of individual 
PBM values that can be assessed at maturity among young healthy 
subjects of both genders. The genetically predetermined trajectory 
can be modified by environmental factors, particularly nutrition and 
physical activity. Figure reproduced from reference [32].
to the end of pubertal maturation. Much less considera-
tion has been given to protein intake, although this macro-
nutrient is essential for adequate accumulation of bone 
tissue during growth, as well as maintenance of the skel-
etal structural integrity throughout life.
Both animal and human studies indicate that low 
protein intake per se could particularly be detrimental 
to bone acquisition. Undernutrition, including inade-
quate supplies of energy and protein during growth, can 
severely impair bone development [63]. An inadequate 
protein supply appears to play a central role in the patho-
genesis of the delayed skeletal growth and reduced bone 
mass that is observed in undernourished children [63]. 
Low protein intake could be detrimental to skeletal integ-
rity by lowering the production of IGF-I [64]. Variations in 
the production of IGF-I could explain some of the changes 
in bone and Ca-Pi metabolism that have been observed in 
relation to dietary protein intake. Indeed, the plasma level 
of IGF-I is closely related to the growth rate of the body. 
In humans, circulating IGF-I progressively rises from 
1 year of age to the onset of pubertal maturation. Then, 
serum IGF-I markedly increases to reach maximal values 
before declining toward adult values [65]. This pattern 
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is in close correspondence to pubertal maturation, peak 
height velocity, and bone mass accumulation rate [65–67]. 
Among healthy individuals, there is a strong positive asso-
ciation between serum IGF-I and BMC accrual from early 
to mid-puberty [68]. As mentioned above, IGF-I appears 
to play a key role in Ca-Pi metabolism during growth by 
stimulating both the tubular Pi reabsorption and produc-
tion of 1,25D at the kidney level [33]. Furthermore, IGF-I 
is considered as an essential factor for bone longitudinal 
growth, as it stimulates proliferation and differentiation 
of chondrocytes in the epiphyseal plate [69–71]. IGF-I also 
increases the external diameter of long bones, probably 
by enhancing the process of periosteal apposition [69–71]. 
Therefore, during adolescence, a relative deficiency in 
IGF-I or a resistance to its action may result in a reduction 
in both longitudinal and cross-sectional bone develop-
ment [69–71].
In “well” nourished children and adolescents, the 
question arises whether or not variations in the protein 
intake within the “normal” range can influence skeletal 
growth and thereby modulate the influence of genetic 
determinants on PBM attainment [72]. Considering the 
relationship between protein intake and bone mass gain, 
it is not surprising to find a positive correlation between 
these two variables [72]. This association appears to be 
particularly significant in prepubertal children [67, 73].
Interaction of protein intake and 
physical activity
Growing bones are usually more responsive to mechani-
cal loading than adult bones. Increased physical activ-
ity was shown to stimulate mineral mass accumulation 
in children and adolescents [74]. Adequate nutritional 
supply can be expected to sustain the anabolic effect of 
mechanical loading on bone tissue, as it does on skeletal 
muscle development. Among nutrients, high Ca intake 
was reported to enhance the response to physical activity 
in healthy children aged 3–5 years [75]. Long-term protein 
consumption exerts a stronger impact on bone mass and 
strength acquisition in healthy children and adolescents 
aged 6–18 years than Ca intake [76]. In prepubertal boys, 
high protein intake was shown to enhance the bone 
response to increased physical activity [77]. At the femoral 
neck level, the increased bone mass was associated with a 
wider external perimeter [77], a macroarchitecture feature 
that should confer greater resistance to mechanical load 
[78]. Of interest, this response tracks from prepuberty to 
mid-late puberty [79]. At this stage of sexual maturation 
in healthy boys, microstructural changes can be recorded 
that should provide greater strength to weight-bearing 
bones [79]. These results underscore the importance of 
protein intake to enhance the bone response to mechani-
cal strain during growth. They strongly suggest that early 
intervention combining protein intake and physical exer-
cise during childhood could induce protracted upward 
shift of the predetermined skeletal trajectory and thereby 
provide substantial benefit to adult bone health [79].
Protein malnutrition and bone 
in relation with intensive exercise 
or anorexia nervosa
Intensive exercise
A positive correlation between protein intake and bone 
mass has been found in premenopausal women [80]. In 
women on a low-calorie diet, insufficient protein intake 
could be particularly deleterious for bone mass integrity. 
In athletes or ballet dancers, intensive exercise can lead 
to hypothalamic dysfunction with delayed menarche and 
disruption of menstrual cyclicity and bone loss [81, 82]. 
In intensive exercise involved women, the combination 
of an eating disorder, menstrual dysfunction, and osteo-
penia has been called the “Female Athlete Triad” [83]. 
Nutritional restriction likely plays an important role in the 
disturbance of the female reproductive system resulting 
from intense physical activity. The propensity to nutri-
tional restriction is more common when leanness confers 
an advantage for athletic performance. Insufficient energy 
intake with respect to energy expenditure is supposed to 
impair the secretion of GnRH and thereby leads to a state 
of hypoestrogenism. However, the relative contribution 
of insufficient protein intake with low IGF-I remains to 
be assessed, as it is frequently associated with reduced 
energy intake.
Anorexia nervosa
In young women, anorexia nervosa is a frequent condition 
[84–86]. Reduced aBMD can be measured at several skel-
etal sites in most women with anorexia nervosa [87]. It is 
not surprising that young women with anorexia nervosa 
are at increased risk of fracture later in life. Body weight, 
but not estrogen use, is a significant predictor of aBMD 
in women with anorexia nervosa [88]. With estrogen and 
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Ca deficiency, low protein intake very likely contributes to 
the bone deficit observed in anorexia nervosa. Circulat-
ing IGF-I, a marker of protein nutrition [24, 89], is low in 
anorexia nervosa (Table  1) [90]. In this situation, serum 
osteocalcin and bone-specific alkaline phosphatase, 
two biochemical markers of bone formation, are signifi-
cantly reduced [91]. In mature adolescents with anorexia 
nervosa, circulating IGF-I was linked to variations in the 
nutritional state and was the major correlate of bone for-
mation markers [91].
Anorexia nervosa patients significantly over-reported 
energy, and probably protein intake [92], notwithstanding 
the unreported use of purging means such as vomiting and 
laxatives [93, 94]. Nevertheless, protein depletion associ-
ated with low lean body mass has been clearly identified 
in anorexia nervosa patients [95]. This finding is in agree-
ment with the decreased serum level of IGF-I found in this 
disease (for recent reviews see [96, 97]) as well as in experi-
mental isocaloric protein depletion [12]. Refeeding ano-
rexia nervosa patients with a diet of which 20% of energy 
was provided by protein significantly increases both lean 
body mass – when rightly calculated in absolute value and 
not related to body weight – and total body protein [95]. 
Thus, anorexia nervosa patients were shown to replenish 
total body protein during nutritional rehabilitation [95].
Effects of high protein diet 
on Ca and bone metabolism 
during energy deficit
Energy deficit (ED), from either reduced dietary intake 
or increased expenditure, is used to induce weight loss 
Table 1: IGF-I and lumbar spine aBMD in anorexia nervosa.
  Anorexia nervosa 
n = 34
  Controls 
n = 33
  p-Value
Age, year   15.9  15.0 
BMI, kg/m2   16.6  22.3  p < 0.001
IGF-I, ng/mL   294  556  p < 0.001
LS aBMD, mg/cm2  893  971  p < 0.001
LS aBMD, Z-score   −0.74  +0.13  p < 0.001
The marked reduction in BMI and in serum IGF-I reflects the 
deficient nutritional status documented in a group of anorexic-
adolescent girls as compared to age-matched controls. The bone 
consequence of anorexia nervosa is expressed by a severe deficit 
in lumbar spine (LS) aBMD, −0.87 Z-score. P-Value: Statistical 
probability for difference between anorexic patients and control 
subjects. Adapted from reference [88].
in overweight or obese subjects [98]. Periods of ED due 
to intense physical activity can also be experienced by 
healthy, normal-weight individuals such as athletes or 
army trainees [99]. Fat mass loss by ED in overweight 
and/or obese individuals can also be detrimental to skel-
etal muscle mass and strength as well as to bone integ-
rity. During ED, the adverse effect on skeletal muscle 
can be attenuated by high protein diet. There has been 
some concern whether high protein diet may aggravate 
ED-induced bone loss [100, 101]. This issue has recently 
been examined in a short-time study in young healthy 
adults  [98]. Increasing the protein consumption from 
0.8 g/kg bw/day [Recommended Dietary Allowance (RDA)] 
to 2.4 g/kg bw/day did not negatively affect Ca homeostasis 
and bone turnover [98]. This observation is in keeping with 
a long-term study in postmenopausal women with ele-
vated BMI showing that a higher protein diet during weight 
reduction increases circulating IGF-I and attenuates total 
and trabecular bone loss at several skeletal sites including 
ultradistal radius, lumbar spine, and total hip [102].
See section on “Dietary protein-IGF-I axis on bone 
mineral economy and metabolism” against the hypothesis 
of a causal relationship between protein intake and sys-
temic acidosis leading to increased bone resorption and 
eventually age-related osteoporosis.
Epidemiological studies on protein 
intake in adult women and in the 
elderly
An early small but often quoted cross-sectional study 
suggested that high protein diet might be detrimental to 
forearm aBMD in limited number of healthy young women 
[103]. However, in several later reports this negative asso-
ciation between protein intake and aBMD or BMC was not 
confirmed in both premenopausal and postmenopau-
sal women. Furthermore, in a large number of studies, a 
positive relationship between protein intake and aBMD 
or BMC has been found (for review see [37, 46]). In the 
Framingham Osteoporosis Study, increased protein intake 
was protective against spinal and femoral bone loss in a 
large cohort of elderly women and men prospectively fol-
lowed over a period of 4  years [104]. As in hospitalized 
elderly patients, those with a higher protein intake had a 
greater aBMD, particularly at the femoral neck level [105]. 
Whereas a gradual decline in caloric intake with age can 
be considered as an adequate adjustment to the usual 
progressive reduction in energy expenditure, the paral-
lel reduction in protein intake is certainly detrimental to 
Brought to you by | Universitaetsbibliothek Basel
Authenticated
Download Date | 4/29/19 4:32 PM
Bonjour: The dietary protein, IGF-I, skeletal health axis      45
both structure and function of several organs or systems 
including skeletal muscle and bone. With aging there is 
a decline in both the intake of protein (Figure 3A) and the 
circulating level of IGF-I (Figure 3B). As mentioned above, 
dietary protein is crucial for bone and muscle develop-
ment. Recent evidence suggests a significant underestima-
tion of protein requirements in adult human, particularly 
in elderly [37, 108, 109, 32]. Thus, increasing protein above 
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Figure 3: Protein intake, serum IGF-I in relation with aging.
The decline with aging in the protein intake and in the serum level 
of IGF-I is depicted in A and B, respectively. (A) The protein con-
sumption was recorded from a representative sample (n = 1453) of 
persons living in two Italian cities. The protein intake considered as 
adequate is indicated above the diagram for both women and men. 
Adapted from reference [106]. (B) The progressive decline in serum 
IGF-I was recorded in 448 healthy subjects from young adulthood 
to old age. The correlation coefficient R between IGF-I and age was 
−0.74 (p < 0.01). The regression lines from the mean and 2 SD are 
shown. Women are represented by circles and men by triangles. 
Adapted from reference [107].
the RDA may help prevent the loss of bone and muscle 
mass in elderly [37, 108, 109, 32].
There is evidence suggesting that the favorable effect 
of increasing protein on aBMD or BMC is better sustained 
when the supply of both Ca and vitamin D is adequate 
[110–113]. Reciprocally, in postmenopausal women with 
low calcium intake (600 vs. 1500 mg/day), a relatively 
high protein consumption (20% vs. 10% of energy intake) 
enhances Ca retention. Likewise, in healthy older women 
and men, protein supplements increasing the daily intake 
from 0.78 to 1.55 g/kg/day, when isocalorically substituted 
to carbohydrates, were associated with higher circulating 
levels of IGF-I and lowered levels of urinary N-telopeptide, 
a marker of bone resorption [114]. These results are com-
patible with a preventive effect of relatively high protein 
intake on bone loss in elderly.
Recent reports from France [115], Canada [116], and 
the United States [117] sustain the notion that high rather 
than low protein intake is beneficial for musculoskeletal 
health in older adults.
The increased risk of mortality associated with low 
protein intake in the elderly has been suggested to be 
related to the increased need for dietary cysteine [118]. 
This amino acid supports the synthesis of glutathione, 
an oxidant scavenger and thereby a key protective factor 
that declines with aging [118]. Elderly patients hospital-
ized with hip fracture are often protein malnourished [119] 
and are at increased risk of mortality [120]. The relation 
between the specific need of dietary cysteine in protein-
malnourished hip fracture patients and the increased risk 
of mortality remains to be established.
Cross-cultural comparison 
of hip fracture incidence
Some cross-cultural studies comparing protein intake and 
hip fracture incidence in women living in various coun-
tries have been interpreted as suggesting that high protein 
intakes from animal source exert deleterious effects on 
bone health [121, 122]. However, the way both terms of this 
putative relationship between protein intake and hip frac-
ture incidence were derived is highly questionable. First, 
the use of per capita food supplies provided by the FAO of 
the United Nations is not a reliable estimate of the protein 
intake of the population at risk of hip fracture. It is calcu-
lated from the total amount of animal protein available for 
the whole population, i.e. the amount produced plus the 
amount imported minus the amount exported by a given 
country, divided by the number of inhabitants. In this 
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rough average estimate of the whole population intake, 
any selective decline in protein consumption with aging 
is not taken into account, as reported in several reviews 
[37, 111, 119, 123]. Second, as expected, countries with the 
highest incidence of hip fracture are those with the longest 
life expectancy. Age adjustment to the 1977 or 1987 distri-
bution of the US women population [121, 122] does not 
correct the marked difference in life expectancy between 
populations of various socio-economic conditions.
Prospective observational studies 
on protein intake and hip fracture
In contrast to this “negative” aspect of protein intake 
hypothesized from cross-cultural analysis, several pro-
spective observational studies have rather shown either 
a protective effect of relatively high protein consump-
tion or, at least, no detrimental effect on hip fracture 
incidence. Low protein intake has been documented in 
elderly subjects at risk of fragility fractures and more so 
in those experiencing hip fracture (for review see [119]). 
It is associated with low BMI as clearly documented in a 
meta-analysis gathering 12 prospective worldwide multi-
center studies including 60,000 men and women with a 
total follow-up of 250,000 person-years [124]. In elderly, 
low BMI is correlated with protein undernutrition that, 
in turn, is associated with low bone and skeletal muscle 
mass [37, 123].
In a large prospective study (Iowa Women’s Health 
Study) including about 32,000 women aged 55–69 years, 
total protein intake was inversely associated with the risk 
of hip fracture (Figure 4) [57]. Thus, the risk reduction in 
hip fracture incidence was 67% and 79% for the highest 
vs. the lowest quartile in total and animal protein intake, 
respectively [57]. In a smaller case-control study includ-
ing both women and men residing in Utah, higher total 
protein intake was associated with a significant reduced 
risk of hip fracture in 50–69-year-old subjects [125]. In 
70–89-year-old residents of this county, however, protein 
intake was not significantly associated with a decreased 
or an increased risk of hip fracture [125]. As discussed by 
the authors, it is unclear whether the lack of protective 
effect in the 70–89-year group would reflect a functional 
difference in nutritional protein metabolism or merely an 
artifact due to methodological limitations of the case-con-
trol study design in the oldest subjects [125]. In both Iowa 
and Utah studies, calcium intake did not modify the risk 
evaluation of hip fracture in relation with protein intake 
[57, 125]. These observations somehow contrast with an 
Hip fracture relative risk
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Figure 4: Reduced incidence of hip fracture with relatively high 
protein intake.
The diagram represents the relative risk of hip fracture according to 
quartiles of total protein intake. The nutrient intake was assessed in 
a cohort of Iowa women aged 55–65 years at baseline. The incident 
hip fractures were ascertained in the follow-up analysis of 104,338 
person-year. The risk of hip fracture was negatively associated with 
total protein intake (Q4 > 12.05 g/MJ vs. Q1 < 9.56 g/MJ, age-adjusted 
relative risk: 0.31), especially from animal sources (Q4 > 9.26 g/MJ 
vs. Q1 < 6.48 g/MJ, age-adjusted relative risk: 0.21) after adjustment 
for age, body size, parity, smoking, alcohol intake, estrogen use, 
and physical activity (p trend = 0.037). Adapted from reference [57].
analysis [126] of results obtained in a large French post-
menopausal women-cohort study initiated in 1990 to iden-
tify most frequent cancer-associated risk factors [127]. In 
short, no association was found between fracture risk and 
either total protein (from animal or vegetable sources) or 
Ca intake [126]. However, further cross-tabulation analysis 
that subdivided the population in four subgroups revealed 
a slightly but significant increased risk when the highest 
quartile of protein intake was combined with the lowest 
quartile of Ca intake [126]. Of note, in this population of 
relatively young postmenopausal women, the daily protein 
intake was normal to high (mean about 1.45 g/kg/day) and 
the Ca intake fairly high (mean about 1045 mg/day) [126]. 
Therefore, this epidemiological study is not relevant to 
elderly women at risk of undernutrition as observed in hip 
fracture patients [13]. In another relatively young cohort 
aged from 35 to 59 years, the “Nurses’ Health Study”, a 
trend for hip fracture incidence inversely related to protein 
intake was found [128]. In the same prospective epide-
miological study, however, forearm fracture  incidence 
was slightly increased [relative risk (RR) = 1.18, 95% con-
fidence interval (CI), 1.01–1.38] in the highest ( > 95 g/day) 
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was given to patients with a recent hip fracture [14]. Both 
protein supplemented and placebo-controlled groups 
were vitamin D replete and received 500 mg of elemental 
Ca daily. The protein supplemented group displayed a sig-
nificantly greater increase in serum IGF-I level (Figure 5A) 
and lessened loss of bone mineral mass at the contralat-
eral proximal femur (Figure 5B), with a trend towards less 
vertebral fracture [14]. Muscle strength improved in the 
protein supplemented group as compared to the isocaloric 
placebo-controlled group [14]. Furthermore, in the protein 
supplemented patients, there was also an improvement 
as compared to the lowest ( < 68 g/day) quintile of age-
adjusted total protein intake [128]. The reason for this skel-
etal site difference in the recorded association might be 
related to physical activity and mode of falling that differs 
for hip vs. forearm fracture [78]. In contrast to the French 
study discussed above [126], as well as to a retrospective 
Norwegian survey [129], no significant relation in the Ca/
protein ratio was found with either hip or forearm fracture 
incidence in the “Nurses’ Health Study” [128].
Meta-analysis of protein intake, 
aBMD or BMC, and hip fracture
Studies reported from 1966 to 2008 on the relation between 
protein and bone integrity in healthy human adults were 
systematically reviewed and meta-analyzed [130]. From 
the 18 studies that could be quantitatively analyzed, a sig-
nificant positive pooled correlation was computed between 
protein intake and aBMD or BMC measured at the main 
clinically relevant skeletal sites [130]. Four suitable hip 
fracture studies [57, 128, 129, 131] were also meta-analyzed 
[130]. In contrast to cross-cultural ecologic studies men-
tioned above [121, 122], no negative association was found 
between the relative risk of hip fracture and the protein 
intake [130]. In relation with protein undernutrition and 
fragility fractures, the risk of spinal and hip fractures was 
associated with low circulating levels of IGF-I [132, 133]. 
Furthermore, in the elderly at risk of osteoporotic fractures, 
marginal dietary protein intake results in loss of muscle 
mass, which is associated with reduced IGF-I plasma level 
[134]. Muscle mass and strength are important determi-
nants of the risk and consequence of falling in elderly [119]. 
There is evidence that the anabolic response of muscle to 
dietary protein is attenuated in elderly and, consequently, 
the amount of protein required to enhance muscle mass is 
greater [37]. Several epidemiological and clinical studies 
point to a beneficial effect of increasing the protein intake 
in elderly above the current RDA of 0.8 g/kg/day to approxi-
mately 1.2 g/kg/day; short-term studies indicated beneficial 
effects of protein intake up to 1.6–1.8 g/kg/day [37].
Intervention study on the impact of 
protein repletion after hip fracture
In a randomized, double-blind, placebo-controlled trial, 
oral protein supplement providing 20 g of casein/day 
during 6 months, as compared to an isocaloric supplement, 
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Figure 5: Effects of protein supplements on serum IGF-I and 
 proximal femur in patients with a recent hip fracture.
The design was a 6-month, randomized, double-blind, placebo-con-
trolled trial with 6-month post-treatment follow-up. All patients (n = 82, 
mean age = 80.7) received calcium supplementation, 550 mg/day, and 
one dose of vitamin D, 200,000 at baseline. They were randomized 
to consume either a protein (casein) supplement, 20 g/day or an 
isocaloric supplement (placebo-controls). (A) Change in serum IGF-I 
from baseline to the end of intervention at month 6 and follow-up at 
month 12. (B) Change in femoral neck aBMD from baseline to month 12 
showing the significant attenuation of bone loss in the protein-supple-
mented group as compared to the isocaloric placebo group. Figures A 
and B are adapted from reference [14].
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in clinical outcomes that were associated with a reduced 
length of stay in the rehabilitation hospital [14].
Thus, dietary protein, by impacting on both bone and 
skeletal muscle anabolism, plays a key role in the preven-
tion of bone loss and sarcopenia, thus reducing the pro-
pensity to fall and the risk of fragility fractures (Figure 6).
Intervention study on the impact 
of whey supplementation 
in  protein-replete women
The beneficial effect size on bone structure of nutritional 
interventions largely depends upon the baseline status of 
the tested nutrient. The highest the status of the nutrient 
is, the lowest the effect size is recorded. This fundamental 
notion should hold true not only for bone but also for in 
any other tissues or systems of the body. Thus, the bone 
effects of vitamin D, Ca, or protein supplementation can 
be expected to be markedly attenuated, even abolished in 
replete individuals. A RCT testing a daily isocaloric whey 
protein supplement of 30 g, given to healthy postmeno-
pausal women, thus increasing the baseline protein con-
sumption from 1.2 to 1.4 g/kg/day, was without beneficial 
or detrimental effect on femoral bone structure [135]. In 
this study carried out in protein-replete healthy women, 
the increase in serum IGF-I at the end of the whey sup-
plementation only reached 8% [135] as compared to 
52% in protein-deplete hip fracture patients in whom 
Increased IGF-I
Increased dietary protein intake
with adequate Ca, Pi and vitamin D supply
Increased bone formation
Improved bone mass and strength 
Reduced fragility fracture risk
Reduced PTH
Improved intestinal
Ca & Pi absorption
Reduced bone resorption
Improved muscle
mass and strength
Reduced inflammatory
cytokines
Enhanced 1,25D synthesis
Reduced
fall propensity
Figure 6: Positive influence of protein intake on bone and skeletal 
muscle health in elderly.
With aging, the impact of dietary protein on both bone and skeletal 
muscle anabolism plays an important role in the prevention of 
osteoporosis and sarcopenia. Dietary protein with calcium and 
vitamin D contribute to attenuate both age-dependent bone loss 
and the propensity to fall, thereby reducing the risk of fragility frac-
ture. Figure reproduced from reference [32].
protein supplementation significantly attenuated the 
post-surgical femoral neck loss as compared to isocaloric 
placebo [14].
Concluding remarks
In the development and maintenance of bone structures 
resistant to usual mechanical stresses, adequate nutri-
tion plays an important part. In addition to Ca associated 
with an adequate supply of vitamin D, dietary protein 
represents a key nutrient for bone health and thereby for 
the prevention of osteoporosis. During growth, protein 
undernutrition from infancy to childhood and adoles-
cence results in reduced bone mass and strength, thereby 
increasing the risk of fragility fracture in later life. On 
the contrary, high protein intake, particularly when 
associated with physical activity, favors healthy bone 
mass acquisition. There is a positive interaction between 
dietary protein, Ca-Pi economy, and bone metabolism. 
This interaction appears to be mediated by the anabolic 
bone trophic factor IGF-I, the hepatic production of which 
is stimulated by dietary proteins. Amino acids such as 
arginine can exert a direct positive effect on the IGF-I pro-
duction by bone-forming cells. In young adulthood, ED, 
as observed in anorexia nervosa, can be associated with 
insufficient protein supply, low circulating IGF-I, bone 
loss, and increased risk of fragility fracture. With aging, 
the reduction in the protein intake is associated in both 
genders with a decrease in the serum level of IGF-I, lower 
femoral neck aBMD, and poor physical performance. 
Protein undernutrition is often present in patients expe-
riencing hip fracture. Furthermore, clinical outcome after 
hip fracture can be significantly improved by normaliz-
ing protein intake, which is associated with a rise in the 
serum IGF-I level. Thus, dietary protein contributes to 
bone health from early childhood to old age and thus is a 
key nutrient in the prevention of osteoporosis.
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